203 related articles for article (PubMed ID: 26757251)
1. Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.
Wang Y; Liu H; Ready NE; Su L; Wei Y; Christiani DC; Wei Q
Int J Cancer; 2016 Jun; 138(11):2592-601. PubMed ID: 26757251
[TBL] [Abstract][Full Text] [Related]
2. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
[TBL] [Abstract][Full Text] [Related]
3. Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.
Tang D; Zhao YC; Liu H; Luo S; Clarke JM; Glass C; Su L; Shen S; Christiani DC; Gao W; Wei Q
Int J Cancer; 2020 Sep; 147(6):1559-1570. PubMed ID: 32072637
[TBL] [Abstract][Full Text] [Related]
4. Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.
Qian D; Liu H; Wang X; Ge J; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
Int J Cancer; 2019 Apr; 144(8):1867-1876. PubMed ID: 30259978
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.
Chen K; Liu H; Liu Z; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
Int J Cancer; 2019 Aug; 145(3):621-631. PubMed ID: 30650190
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy.
Kim SH; Kim MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY; Ling H; Lee GW
Am J Clin Oncol; 2015 Jun; 38(3):294-9. PubMed ID: 23689644
[TBL] [Abstract][Full Text] [Related]
10. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
12. Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.
Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
Cancer Immunol Immunother; 2021 Oct; 70(10):2819-2833. PubMed ID: 33651148
[TBL] [Abstract][Full Text] [Related]
13. Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.
Tang D; Zhao YC; Qian D; Liu H; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Glass C; Gao W; Wei Q
Mol Carcinog; 2020 Jan; 59(1):104-115. PubMed ID: 31713888
[TBL] [Abstract][Full Text] [Related]
14. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
[TBL] [Abstract][Full Text] [Related]
15. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
Qian CY; Zheng Y; Wang Y; Chen J; Liu JY; Zhou HH; Yin JY; Liu ZQ
Chin J Cancer; 2016 Sep; 35(1):85. PubMed ID: 27590272
[TBL] [Abstract][Full Text] [Related]
16. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract][Full Text] [Related]
17. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
18. Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
Xu Y; Liu H; Liu S; Wang Y; Xie J; Stinchcombe TE; Su L; Zhang R; Christiani DC; Li W; Wei Q
Int J Cancer; 2018 Nov; 143(10):2400-2408. PubMed ID: 29978465
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
Müller PJ; Dally H; Klappenecker CN; Edler L; Jäger B; Gerst M; Spiegelhalder B; Tuengerthal S; Fischer JR; Drings P; Bartsch H; Risch A
Int J Cancer; 2009 Apr; 124(7):1669-74. PubMed ID: 19107936
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.
Chen AS; Liu H; Wu Y; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Wei Q
Mol Carcinog; 2022 Jul; 61(7):619-628. PubMed ID: 35502931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
